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A  total  immunological unresponsiveness  (tolerance)  to  serum protein  anti- 
gens  can  be  induced  in  rabbits  by neonatal  injection  of the  protein  (1-13). 
This  tolerance  lasts for a  considerable period of time  after  the rabbit  reaches 
maturity (8) and is specific (1,  7).  A similar total tolerance of shorter duration 
has  been  induced  in  mice  (14)  and  a  partial  tolerance  has  been  induced  in 
chickens  (15-19).  The ability of specifically tolerant  animals  to produce anti- 
bodies  against  antigens  related  to  the  antigen  used  to  induce  tolerance  has 
been studied previously (6,  7,  12). The present study was designed to  observe 
the  effect of the injection  of tolerant  rabbits  with  antigens  related  to  the in- 
ducers of tolerance on the tolerant state itself. 
Materials and Methods 
Antigens.'Commereial preparations  of serum albumins were obtained from the following 
sources: bovine, Armour and Co., Lot V68802; human,  Squibb, Lot 591R; dog, pentex, Lot 
33F01; sheep, pentex,  Lot 140G01; horse, pentex, Lot 39F02; and pig, pentex, Lot 5701:01. 
Serum albumin from mouse, dog, and hamster were prepared by fractinnation of whole serum 
(20) and purified by the method  described by Schwert  (21). The serum albumins prepared 
in this manner showed a purity of 97 per cent as determined by paper electrophoresis. Bovine 
gamma globulin (BGG) was purchased  from Armour  and Co.  (Lot C-904). Bovine serum 
albumin  (BSA) was trace labeled with  I TM  (I*)  by the method  previously described (11). 
Protein-bound I* activity was determined in either well-type gamma counters or NaI crystal 
scintillation counters. The specific activity (counts/#g N) of the I* BSA was determined so 
that I* activity could be coaverted to #g of BSA N. 
Antisera.--Anti BSA and anti BGG were obtained  from hyperimmunized albino rabbits 
prepared  by a series of injections of either BSA or BGG given over a 2 to 4 month period, 
totaling 250 to 300 rag. The last injection was given 7 days before bleeding. The sera obtained 
from 15 rabbits  were pooled. 
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Induction  of Immunological Tolerance to BSA.--Rabbits  were made tolerant to BSA by 
the method previously described  (9,  10). Newborn rabbits were given several injections of 
BSA during the first  5  days  after  birth,  totaling  500  rag.  Prior  to  each experiment,  each 
rabbit (at age of 3 to 4 months) was injected with 20 mg of I* BSA, and the failure to show 
an immune elimination of the I* BSA over a 13 day period was used as an index of a tolerant 
state. Under these conditions, 100 per cent of the rabbits were tolerant. 
Injection of Heterologous Albumins.--BSA-tolerant  rabbits were given four daily subcuta- 
neous injections of 20 rag of human, pig, sheep or bovine albumin. On the 5th day they re- 
ceived an intravenous injection of 30 mg/kg, body weight of the same albumin.  The series 
of injections was repeated 2 weeks later. BSA-tolerant rabbits were also  injected in a  similar 
manner with BGG.  Five days after the last  injection, all of  the rabbits were bled  and  the 
sera tested for anti-BSA and antibody against the heterologous albumin used for immuniza- 
tion. 
Elimination  of I* BSA from the Circulatlon.--Ixamediately  following the antibody bleed- 
ing, the tolerant rabbits were injected intravenously with 20 mg I* BSA and bled periodically. 
The sera were analyzed for both I* BSA and for I* BSA-anti BSA complexes.  I* BSA com- 
plexes were measured by determining the amount of I* BSA bound to the globulins precipi- 
tated at 50 per cent ammonium sulfate saturation  (22). The immune elimination of I* BSA 
was used as evidence of the loss of the tolerant state. 
Antibody  Determinations.--Precipitating  antibody  was  measured  by  the  quantitative 
immunochemical  procedure  described  by  Heidelberger  and  coworkers  (23).  In  situations 
where the levels of precipitating antibody were low and  could not be accurately measured 
with this procedure, a quantitative technique (24), employing I* antigen, was utilized. Other 
tests for antibody were performed by:  (a)  a  modification of the Takatsy hemagglutination 
technique  (25),  employing formalized rabbit  erythrocytes  (26);  (b)  the ammonium sulfate 
technique of Farr (27); and (c) the double diffusion in agar technique. The ammonium sulfate 
technique was performed with 1.0/zg I* BSA N and increasing dilutions of antisera, and the 
results are reported as the/zg of I* BSA N  bound to the globulin in 1 ml of serum. Double 
diffusion  in agar was performed by a modification of the technique described by Ouchterlony 
(28).  An 0.7 per cent solution of Ionagar 2, purchased from Consolidated Laboratories, Inc., 
Chicago Heights, was prepared and pipetted  on glass  plates over a  40 x 40 mm area. The 
borders of the area were contained by placing microscope slides on the glass plates. Three to 
4 ml of agar were used to fill the 40 x 40 mm area to a  depth of 2.0 ram. The antigen and 
antibody wells were cut in the cooled agar.  Plates prepared in this manner could be washed 
free of the unbound  protein,  dehydrated,  and  then  stained  with azoearmine  G  or  amido 
Schwartz.  A permanent record of the reactions was then available. Double diffusion in agar 
was performed with concentrated sera and varying concentrations of the antigens. 
RESULTS 
BSA-Tolerant  Rabbits  Injected  with  Human  Serum  Albumin  (HSA).--Five 
BSA-tolerant  rabbits  and  five  normal  rabbits  of  approximately  the  same 
weight and age were given a  series of injections of HSA, and both the antibody 
produced  and  the  result  of  a  subsequent  injection  of  I*  BSA  were  studied 
(Table  I).  Both  groups  of  animals  produced  high  levels  of  antibody  which 
precipitated  with  HSA, although  more  anti-HSA was produced  in the normal 
group than in the tolerant group.  Sera from the normal group also precipitated 
with  BSA,  while sera  from  the  BSA-tolerant  group  did  not.  Four  of  the  five 
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of HSA, since  they showed an immune elimination of a  subsequent  injection 
of  I*  BSA,  and  their  sera  contained  anti-BSA  when  analyzed  by  the  Farr 
technique.  The sera from the normal rabbits cross-reacted with all four of the 
heterologous  albumins  tested,  while  sera  from  the  tolerant  rabbits  showed 
much  less diversified cross-reactivity with  heterologous albumins.  Five BSA- 
tolerant rabbits not injected with HSA showed no antibody to BSA or HSA 
and  no  immune  elimination  of I* BSA.  Table  II shows  results  obtained  in 
TABLE I 
Serological Changes in BSA-Tolerant Rabbits Following Injeaions of HSA 
Rabbit No. 
Tolerant 
79-44 
79-45 
79-46 
79-48 
79-49 
Normal 
80-37 
80-39 
80-40 
80-41 
80-42 
Antibody  N 
precipitated 
with  with 
HSA  BSA 
~g 
410.0 
406.0 
288.0 
132.8 
334.0 
824.0 
502.0 
804.0 
544.0 
242.8 
Cross- 
reaction 
per cent 
o 
o 
o 
o 
o 
o  5 
1  4 
6  9 
8  lO 
2  5 
BSA- 
Binding 
¢apacity~t 
7.2 
7.3 
14.5 
0.0 
4.0 
51.5 
8.2 
104.3 
87.1 
7.9 
Immune 
elimina- 
tion of 
I ° BSA§ 
+ 
+ 
+ 
+ 
Reaction in agar with various albumins 
Bovine  Sheep  Pig  Mouse  Dog 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
:~The  #g  I*  BSA  N  bound  by  the  globulin  fraction  (precipitated  with  50  per 
cent  (NI-I,)2SO~)  of 1 ml sera. 
§ 20 mg I* given intravenously following antibody bleeding. 
another  experiment  with  nine  BSA-tolerant rabbits  injected  with  HSA.  At 
least  eight  of  these  rabbits  rapidly  eliminated  a  subsequent  injection  of I* 
BSA (Fig.  1) at a rate consistent with that of a  secondary response. All of the 
nine  tolerant  rabbits  produced  anti-BSA  hemagglutinins  and  anti-BSA  as 
detected by the  Farr technique.  The one  tolerant rabbit which  did not give 
an immune elimination of I* BSA did have a small amount of non-precipitating 
anti-BSA in its serum. Whether this response was the result of temporary loss 
of tolerance, or a  production of anti-BSA insufficient to eliminate the I* BSA 
from the circulation, cannot be evaluated. Five of the BSA-tolerant rabbits in 
this  latter  experiment produced  small  amounts  of precipitating  anti-BSA  as 
detected  by precipitation in both fluid  media and  agar.  Again,  the antibody 114  IMMUNE RESPONSES IN TOLERANT RABBITS 
produced  in  the  tolerant  rabbits  with  heterologous  albumins  did  not  cross- 
react as widely as did the antibody produced in the normal rabbits. The sera 
of nine BSA-tolerant rabbits injected with BSA and five BSA-tolerant rabbits 
not  injected showed no precipitation with HSA or BSA, no non-precipitating 
TABLE II 
Serological  Changes in  BSA-Tolerant  Rabbits  Following  Injections  of  HSA 
Rabbit No. 
Antibody N 
precipitated 
with  with 
HSA  BSA 
Hemag-  BSA-  Immune 
Reaction in agar  with various  albumins 
83-15 
83-16 
83-17 
83-18 
83-19 
83-20 
83-21 
83-22 
83-23 
9 rabbits¶ 
5 rabbits 
t*g  #g 
389.11 
332.61 
811.7 I 
231.7 
471.1 
130.6] 
23.11 
174.7] 
637,7[ 
2.3  0.6 
2.1  0.6 
2.6  0.3 
0 
3.1 
0 
0 
0 
3.7 
p~r cen~ 
BSA-Tolerant Rabbits  Injected with 
2561  13.9[  +  -}- 
4096[ 11.6  ,  +  q- 
10241  18.2  [ 
0  1024l  6.5 
0.7  10241  15.8 
0  20481  11.2 
0  ,~,  4.0 
0  1024[ 11.2 
0.6  4096I  15.8 
HSA 
+ 
+  +  -- 
.-[-  --  -- 
+  +  - 
.3f-  __  __ 
-3 V  --  -- 
+  +]+ 
BSA-Tolerant Rabbits  Injected  with BSA 
0  I0  [  [  0  [  -  I--[-- 
BSA-ToIerant Rabbits--Not Injected 
°!°  !  L°i-i-1- 
-  +  + 
-  +  + 
-  -i+ 
-  -i2 
-  -i+ 
+I+  + 
+  + 
+  + 
+  + 
+  + 
+  + 
:~ Results given as the reciprocal of the highest dilution showing  agglutination of BSA~ 
sensitized erythrocytes. 
§The  #g  I*  BSA  N  bound  by  the  globulin  fraction  (precipitated  with  50  per 
cent (NtLL)2SO4) of 1 ml sera. 
[l 20 mg I* BSA given intravenously following antibody bleeding. 
¶ At the time of antibody bleeding,  all rabbits contained circulating BSA in their sera 
(tested for by double diffusion in agar with anti-BSA). 
antibody to HSA or BSA, and no  reaction with other heterologous albumins. 
The  control  rabbits,  also,  showed  no  immune  elimination of an  injection of 
I* BSA 
Following the injection of I* BSA into BSA-tolerant rabbits, previously in- 
jected  with  HSA,  soluble I*  BSA-anti BSA  complexes appeared  in  the  sera 
just prior to, and during, the immune elimination of I* BSA. I* BSA-anti-BSA 
complexes were not  detected in  the  sera of these rabbits when  they were  in- 
jected with I* BSA prior to injection of HSA.  In addition, soluble complexes WILLIAM  O.  W]~IGLE  115 
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FIG. 1. Elimination of I* BSA from the blood of BSA-tolerant rabbits immunized with HSA. 
did not appear in the sera of five control tolerant rabbits at any time during 
the 13 days following injection of I* BSA. 
BSA-Tolerant  Rabbits Injected with Pig Serum Albumin (PSA).--Five  BSA- 
tolerant rabbits and five normal rabbits of approximately the same weight and 
age were given a  series of injections of PSA, and both the antibody produced 
and the effect of a  subsequent injection of I* BSA were studied (Table III). 116  IMMUNE RESPONSES IN  TOLERANT  RABBITS 
All  of  the  normal  rabbits  produced  antibody  which  precipitated  with  both 
PSA and BSA. Two of the BSA-tolerant rabbits produced considerable  levels 
of  antibody  precipitating  with  PSA,  and  another  tolerant  rabbit  produced 
only  a  small  amount  of  anti-PSA.  The  two  remaining  tolerant  rabbits  pro- 
duced no anti-PSA.  The two rabbits  (79-42 and  79-43), which produced large 
amounts  of anti  PSA,  lost  their  tolerance  to  BSA,  since  they showed an  ira- 
TABLE III 
Serological Changes in BSA-Tolerant Rabbits Following  Injections of Pig Serum Albumin 
Rabbit No. 
Tolerant 
79-39 
79-40 
79-41 
79-42 
79-43 
Normal 
79-56 
79-57 
79-58 
79-59 
79-60 
Antibody  N 
precipitated 
with PSA  with BSA 
~g  ~g 
35.2  0 
0  0 
0  0 
944.0  0 
678.0  0 
1163.0  372.8 
432.O  96.0 
44.0  38.6 
396.0  86.8 
1206.0  278.8 
I-Iel~la~g  ~c~.o~  ~(~A~)  ,cross-  . 
~er  cent I 
0  0 
0  0 
0  0 
0  64 
0  8 
32  1024 
22  1024 
87  128 
22  1024 
23  4096 
BSA-  I  I  "Into'uric 
 ind ,.  - 
aim  lty~ ii, BSAII 
0 
0 
0 
23.4  + 
7,9  + 
297,0 
178.0 
89.1 
83.8  i 
363.0 
Reaction  in  agar  with 
various albumins 
__%e 
+  +  +  + 
+  +  +  +  + 
+  +  +  +  + 
+  +  +  +  + 
+  +  +  +  - 
+  +  +  +  + 
Results  given as reciprocal of the highest  dilution  showing agglutination  of BSA-sen- 
sitized erythrocytes. 
§The  gg  I*  BSA  N  bound  by  the  globulin  fraction  (precipitated  with  50  per 
cent (NH4),SO4) of 1 ml sera. 
ii 20 mg I* BSA given intravenously  following antibody bleeding. 
mune elimination of a subsequent injection of I* BSA, and their sera contained 
hemagglutinins  to BSA and antibody capable  of binding  I* BSA.  The  serum 
of one of these  two  rabbits  (79-42)  precipitated  in  agar with  BSA and  all  of 
the  heterologous  albumins  tested.  The  remaining  four  tolerant  rabbits  did 
not  form precipitin  bands  in  agar  with  either  BSA or  the  heterologous albu- 
mens tested. All of the sera from the normal rabbits, including one serum which 
had only 44 ~g of anti-PSA N, formed precipitin bands in agar with BSA and 
all of the heterologous albumins  tested.  The sera of five BSA-tolerant rabbits 
not  injected  with  PSA  contained  no  antibody  to  either  PSA  or  BSA.  These 
five rabbits  also showed no immune elimination of an injection of I* BSA. 
BSA-Tolerant  Rabbits  Injected  with Sheep  Serum  Albumin  (SSA).--Seven WILLIAM O.  WEIGLE  117 
BSA-tolerant rabbits and five normal rabbits of approximately the same weight 
and age were given a  series of injections of SSA, and both the antibody pro- 
duced and the effect of a  subsequent injection of I* BSA were studied (Table 
IV). All of the normal rabbits produced antibody which precipitated with SSA 
TABLE IV 
Serological  Changes  in  BSA-Tolerant  Rabbits  Following  Injections  of Sheep  Serum  Albumin 
Rabbit No. 
i 
Tolerant 
79-50 
79-51 
79-52 
81-42 
81-43 
81-44 
81-45 
Normal 
81-48 
81-49 
81-50 
81-51 
81-52 
Antibody  N 
precipitated  Hemag-  BSA- Immune 
Cross- glutina-  binding ~limlna- 
reaction  tion  eapac- tion  of 
with  with  (BSA)§  ityl[  I* BSA¶  .g 
SSAt  BSA  m 
t~g  /zg 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
per cent 
0  0  0  -- 
0  0  0  -- 
0  0  0  -- 
0  0  0  -- 
0  0  0  -- 
0  0  0  -- 
0  0  0  -- 
254.8  86.8  34  59.4 
736.0  442.0  60  145.2 
50.4  29  2  57  16.8 
1248.0  654.0  62  198.0 
1930.0  500.0  54  156.8 
Reaction  in agar with various albumins 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
m 
+ 
+ 
+ 
+ 
+ 
:~ At the time of antibody bleeding,  all BSA-tolerant rabbits contained circulating SSA 
in their sera (tested for by double diffusion in agar with rabbit anti-sheep serum albumin). 
§ Results given as the reciprocal of the highest dilution showing agglutination of BSA- 
sensitized erythrocytes. 
[I The  #g  I*  BSA  N  bound  by  the  globulin  fraction  (precipitated  with  50  per 
cent (NI~)sSO4) of I ml sera. 
¶ 20 mg I* BSA given intravenously following antibody bleeding. 
and BSA. The sera of the normal animals also formed bands in agar with most 
of the six heterologous albumins tested. In contrast, the BSA-tolerant rabbits 
produced no antibody capable of reacting with either SSA or BSA, nor did sera 
from these animals form precipitin bands in agar with any of the heterologous 
albumins  tested.  In  addition,  the  BSA-tolerant rabbits did not  show  an  im- 
mune  elimination of a  subsequent  injection of  I*  BSA.  At  no  time  did  the 
tolerant animals contain circulating I* BSA-anti-BSA complexes following the 
injection of I*  BSA.  Thus,  the  BSA-tolerant  animals neither produced  anti 
SSA, nor lost their tolerance to BSA. 118  IMMUNE  RESPONSES  IN  TOLERANT  RABBITS 
BSA-Tolerant  Rabbits  Injected  with  Bovine  Gamma  Globulin (BGG).--In 
order to test the specificity of the ability of cross-reacting  serum albumins to 
cause loss of tolerance in BSA-tolerant rabbits, five BSA-tolerant rabbits were 
given a  series of injections of BGG.  All of these  animals  produced antibody 
which precipitated with BGG (Table V), but  there was no antibody in  their 
sera which reacted with BSA, nor did these rabbits show an immune elimination 
of a  subsequent injection of I* BSA. 
TABLE  V 
Serological Changes in BSA-Tolerant Rabbits Following Injections  of BGG 
i 
Antibody N precipitated 
Hemagglutina-  Rabbit No.  tion  (BSA)§ 
with BGG  with BSA~:  t 
I 
#g  /~g.  I 
83-33  201.6  0  0  ! 
[ 
83-34  179.2  0  0  I 
i  83-35  347.2  0  0  ] 
83-36  217.6  0  0  L 
83-37  747.0  0  0  I 
BSA-binding  Immune elimi- 
capacityl]  nation  of I* 
BSA¶ 
0 
0 
0 
0 
0 
Analyzed by both quantitative precipitin and double diffusion in agar techniques. 
§ Results given as the reciprocal of the highest dilution showing agglutination of BSA- 
sensitized erythrocytes. 
[] The  #g  I*  BSA  N  bound by  the  globulin  fraction  (precipitated  with  50  per 
cent (NI-I4)2SO,)  of 1 ml sera. 
¶ 20 mg I* BSA given intravenously following antibody bleeding. 
DISCUSSION 
Mature  rabbits made  tolerant  to  BSA by neonatal  injections  of BSA  lost 
their  tolerant  state when  injected  with  certain  heterologous  albumins which 
cross-react with anti-BSA. The ability of a heterologous  albumin to cause loss 
of tolerance to BSA depended  upon  the degree of serological relationship be- 
tween that heterologous  albumin  and BSA (Table VI). Heterologous albumins 
distantly related to BSA were more effective in producing  a  loss of tolerance 
than  albumins more closely related.  Twelve of fourteen BSA-tolerant rabbits 
lost their tolerance following a series of injections of HSA but none of the seven 
BSA-tolerant rabbits lost its tolerance following a  series of injections of SSA. 
HSA and SSA cross-react 15 and 75 per cent, respectively, with rabbit anti-BSA 
(20):  Two of five BSA-tolerant rabbits lost their tolerance to BSA following a 
series of injections of PSA which cross-reacts 32 per cent with rabbit anti-BSA. 
Downe (5), who made neonatal rabbits tolerant to chicken serum and injected 
them with  turkey serum at maturity, observed antibody in  their sera which 
precipitated with turkey serum but not with chicken serum. Similarly, Curtain WILLIAM  O.  WEIGLE  119 
(12)  injected  rabbits  made  tolerant  to  Bence-Jones  protein  with  an  anti- 
genically related myeloma globulin and found antibody in the sera which re- 
acted with myeloma globulin but not with Bence-Jones protein. The amount of 
anti-BSA produced in BSA-tolerant rabbits following injections of either HSA 
or PSA was extremely small in comparison to the amount produced in normal 
rabbits injected with these antigens. Precipitating anti-BSA was  observed in 
the sera of only six of the sixteen rabbits which lost their tolerance to BSA. 
BSA-tolerant rabbits not only failed to lose  their tolerance to BSA following 
injections of SSA, but they failed to make a detectable response to the portion 
of the SSA molecule not related  to BSA. That SSA has determinant groups 
present on its surface which are serologically distinct from any of the determi- 
TABLE VI 
The Loss of the Tolerant State  of BSA-Tolerant Rabbits Injected  with Cross-Reacting 
Iteterologous Serum Albumins 
Cross-reaction with  Fraction of rabbits losing 
Source of albumin  anti-BSA~  tolerance 
I-Iuman .............................. 
Pig .................................. 
Sheep ................................ 
Bovine  ............................... 
15 
32 
75 
lOO 
12/14 
2/5 
0/7 
O/9 
5~ Pooled hyperimmune  rabbit sera (reference 20). 
nants present on BSA has been previously reported (20).  Similarly, two BSA- 
tolerant rabbits failed to make antibodies to PSA following injections of PSA. 
In agreement with this observation are the findings of Cinader and Dubert (6) 
who showed  that only two  of six HSA-tolerant rabbits  showed an  immune 
response  to injections of a  diazo-p-benzenesulfonic acid derivative of human 
albumin (DHSA) which produces an extensive cross-reaction with rabbit anti- 
HSA.  Thus, it appears  that tolerance to serum protein antigens is not only 
directed to  the individual determinant groups but also  to  the over-all anti- 
genicity or chemical-physical properties  of the  antigen.  It  may be  possible, 
however, to produce antibodies to the SSA determinants which are not related 
to  BSA  by  injecting  the  BSA-tolerant  rabbits  with  SSA  incorporated  in 
Freund's adjuvant. Curtain (12) reported that rabbits made tolerant to either 
normal or abnormal human serum globulins were capable of making antibody 
to closely related globulins injected after incorporation into Freund's adjuvant. 
The mechanism by which injections of albumins cross-reacting with BSA into 
BSA-tolerant rabbits resulted in a loss of the tolerant state is not understood. 
There are, however, several possible mechanisms which could account for this 120  IM~[17N'E  RESPONSES  IN  TOLERAIqT  RABBITS 
phenomenon. Tolerance may be directed to both the over-all antigenicity or 
general  physical-chemical properties  of the  antigen  and  also  the  individual 
determinants on the antigen molecule. Thus, SSA may not be recognized as an 
antigen in BSA-tolerant rabbits because of its over-all antigenic or physical- 
chemical similarity to BSA, while HSA may be recognized as an antigen because 
of its over-all antigenic or physical-chemical dissimilarity to BSA.  Once the 
HSA surmounts the first barrier and is recognized as being antigenic on the 
basis of its over-all properties, then it is confronted with a second barrier, which 
would be recognition of the individual determinants as being antigenic or non- 
antigenic.  In a  BSA-tolerant rabbit,  an immune  response would be made to 
the determinants on HSA not related to BSA, and possibly to  some related 
determinants, if the second barrier is not a complete tolerance to these related 
determinants. The amount of antibody made to the related determinants may 
depend upon the degree of tolerance which is established toward the original 
determinants.  Injections of SSA would not be expected to cause either BSA- 
tolerant rabbits to lose their tolerance or to produce anti-SSA, since the over-all 
antigenicity or physical-chemical properties of this albumin would not permit 
it to carry the related or unrelated determinants past  the first barrier.  The 
ability of a BSA-tolerant rabbit to accept BSA or any heterologous albumin as 
a  non-antigenic substance would depend,  therefore, on the ability of the  al- 
bumin to be recognized as similar to BSA, primarily on its over-all antigenicity 
or physical-chemical composition, and secondarily on its individual determinant 
groups. The results obtained with BSA-tolerant rabbits injected with PSA are 
also consistent with this hypothesis. The two rabbits which made a  good re- 
sponse to PSA went on to make antibody reacting with BSA, while the two 
rabbits which did not make a response to PSA failed to make antibody reacting 
with  BSA.  An  alternate  explanation  for  the  ability  of  injection  of  certain 
heterologous albumins to cause BSA-tolerant rabbits to lose their tolerant state 
is the relative location of the related determinants on BSA and on the heterolo- 
gous albumins. The BSA-tolerant rabbit may not need to be entirely tolerant 
to a partially hidden determinant on BSA. The tolerant rabbit, however, may 
make an antibody response to the same determinant if it is more prominently 
placed on HSA or PSA. The loss of the tolerant state could also be the result 
of a mutation of antibody producing cells which arise from cellular proliferation 
during the immune response to the heterologous albumins. This latter sugges- 
tion would  be in  agreement with  the  failure of injection of SSA  into  BSA- 
tolerant rabbits to result in a production of anti-SSA or in a loss of the tolerant 
state. If the loss of tolerance was the result of a mutation of cells arising from 
cellular proliferation, this mutation would have to be specific for cells which 
proliferate during  the  response to heterologous albumins,  since  injections of 
BGG into BSA-tolerant rabbits result in a good immune response but not in a 
loss  of the  tolerant state.  BGG  does  not  show  a  cross-reaction with  rabbit WILLL-kM O,  WEIGLE  121 
anti-BSA (Fig. 2), although Timourian and Schechtman  (29)  reported a  3 to 6 
per  cent  cross-reaction  between  BSA  and  rabbit  anti-BGG.  These  workers 
found  that there was a  70  to 80 per cent depression in  the capacity of BGG- 
tolerant rabbits to produce antibodies to BSA. However, both this depression 
in capacity to produce antibody to BSA and the 3 to 6 per cent cross-reaction 
between BSA and anti-BGG were probably the result of BSA present in com- 
mercially prepared  BGG preparations. 
The present results can be discussed in relationship to autoimmune diseases 
if it is accepted  that  the  tolerance of neonatal  rabbits  to heterologous  serum 
proteins is similar to the tolerance to their own body constituents.  The ability 
FIG. 2. The serological reactions of a mixture of BGG and BSA with rabbit  anti-BGG 
and rabbit anti-BSA. 1, anti BGG; 2, anti BSA; and 3, BGG and BSA. 
of injections of cross-reacting  albumins  to  cause BSA-tolerant rabbits to  lose 
their  tolerance suggests  that  it may also be possible to  cause animals  to  lose 
tolerance to their own body constituents by exposing them to antigens which 
cross-react with  their  own  constituents.  Goodman  (30)  reported  that  rabbits 
injected  with  nucleoprotein  extracted  from human  liver produced  antibodies 
which  would  react  with  both  human  liver  nucleoprotein  and  extracts  from 
rabbit liver. Heller and Yakulis (31)  showed that guinea pigs injected with con- 
nective tissue extracts of rabbits developed antibodies which would react both 
with  rabbit  and  guinea  pig  connective  tissues  and  also  developed  a  disease 
manifested by stunted growth. Milgrom and Witebsky (32)  also reported that 
rabbits developed antibodies to their own gamma globulin when they were in- 
jected  with  gamma globulin  prepared  by fractionation  of whole  serum  with 
ammonium sulfate.  The  reaction  of  the  rabbit  sera  was much  stronger  with 
gamma globulin of foreign  species than with gamma globulin from the rabbit. 122  IMMUNE  RESPONSES  IN  TOLERANT  RABBITS 
It was concluded that the antibody produced was stimulated by the  animals' 
own gamma globulin which had  undergone changes during  the  fractionation 
with ammonium sulfate. At the present, experiments in our laboratory are being 
performed to attempt to cause BSA-tolerant rabbits to lose  their tolerance to 
BSA by injecting them with chemically, physically, and enzymatically altered 
BSA. 
The relative ease with which rabbits become tolerant to heterologous serum 
proteins in comparison to bacterial antigens (8) may be explained on the basis 
of the antigenic and physical-chemical similarity of the heterologous proteins 
to the serum proteins of the rabbit.  Considering the extensive and diversified 
cross-reactions  among  mammalian  serum  proteins  (33  36,  20),  the  normal 
rabbit is probably partially tolerant to any given heterologous protein, since 
the serum proteins of rabbits are probably serologically related to most heter- 
ologous serum proteins. Differences in other properties, such as ability to circu- 
late in  the body and ability to reach all  the  tissues after injection, may also 
play an important role in determining the ability of heterologous serum pro- 
teins and  bacterial antigens  to induce  tolerance in rabbits. 
Rabbits  injected with 500  mg. of BSA during neonatal life not only fail to 
show an immune  elimination of a  subsequent injection of I* BSA given 3  to 
4 months later, but fail to make even small amounts of anti-BSA which could 
complex with the circulating I* BSA. Bussard (37) reported that rabbits made 
tolerant  to yeast glucose-6-phosphate dehydrogenase by neonatal injection of 
2 mg of the enzyme made small amounts of antibody which  were capable of 
complexing with  circulating antigen,  but  which  were insufficient to  cause all 
immune elimination of the antigen. Probably as a result of the small amount of 
antigen injected into the neonatal animals,  however, the tolerance produced by 
Bussard was not total for all the animals and was readily lost. 
SUMMARY 
Immunological tolerance produced in rabbits by neonatal injections of BSA 
can be terminated by a  series  of injections of  certain heterologous serum al- 
bumins  which  cross-react with  BSA.  Injections of albumins  distantly related 
to BSA were more effective in terminating the tolerant  state than injections of 
albumins closely related to BSA. It  was concluded from results obtained with 
several heterologous albumins that immunological tolerance to BSA is directed 
to both the over-all antigenic or physical-chemical composition of the protein 
and the individual determinant groups present on the protein. Several possible 
mechanisms  were  given  to  explain  the  ability  of  cross-reacting  albumins  to 
terminate the tolerant state of BSA-tolerant rabbits. 
A possible relationship between the termination of tolerance in BSA-tolerant 
rabbits injected with cross-reacting albumins and autoimmunity was discussed. 
It was also suggested that the relative ease with which tolerance could be estab- WILLIAM" O.  WEIGLE  123 
lished to heterologous serum proteins in comparison to bacterial antigens is the 
result of the close serological and physical-chemical relationship of the heterolo- 
gous serum proteins to the serum proteins of the rabbit. 
Rabbits injected with 500 mg of BSA during the first 5 days of life failed to 
form antibody capable of either eliciting an immune elimination of an injection 
of I* BSA given 3 to 4 months later or complexing with the circulating I* BSA. 
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